Literature DB >> 15695146

Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.

Daniela Husser1, Martin Stridh, Leif Sornmo, Christoph Geller, Helmut U Klein, S Bertil Olsson, Andreas Bollmann.   

Abstract

This study explored time-frequency analysis of surface electrocardiograms in patients with persistent atrial fibrillation for monitoring atrial drug action. Drug loading over 3 days with oral flecainide (n = 13) or amiodarone (n = 17) organized the fibrillatory process expressed by decreased atrial fibrillatory rate, increased rate stability, and decreased exponential decay. Effects were more pronounced with flecainide than with amiodarone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695146     DOI: 10.1016/j.amjcard.2004.10.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Right atrial organization and wavefront analysis in atrial fibrillation.

Authors:  Ulrike Richter; Andreas Bollmann; Daniela Husser; Martin Stridh
Journal:  Med Biol Eng Comput       Date:  2009-10-15       Impact factor: 2.602

2.  Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.

Authors:  Nils Edvardsson; Maria Aunes; Lars Frison; Anders R Berggren
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-08-05       Impact factor: 1.468

3.  Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.

Authors:  Helena Carstensen; Eva Zander Hesselkilde; Maria Mathilde Haugaard; Mette Flethøj; Jonas Carlson; Steen Pehrson; Thomas Jespersen; Pyotr G Platonov; Rikke Buhl
Journal:  J Cardiovasc Electrophysiol       Date:  2019-01-28

Review 4.  Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?

Authors:  Alexander Burashnikov
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.